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Synthetic approaches and applications of
sulfonimidates
Priscilla Mendonça Matos*a,b and Robert A. Stockman *a
This review article explores the synthesis of the organosulfur(VI) species named sulfonimidates, focusing on
their synthesis from sulfur(II), sulfur(IV) and sulfur(VI) reagents, and investigates their recent resurgeance in inter-
est as intermediates to access other important organosulfur compounds. Sulfonimidates have been utilized as
precursors for polymers, sulfoximine and sulfonimidamide drug candidates and as alkyl transfer reagents.
1. Introduction
The discovery of sulfonimidate synthesis over 50 years ago1
has arguably allowed the development of this class of organo-
sulfur compounds to be intensively studied and flourish over
time.2 In this review article, we describe specifically the syn-
thesis of these important sulfur-containing compounds, and
their subsequent transformations to other sulfur(VI) derivatives
including sulfonimidamides3 and sulfoximines,4 the latter of
which has increased prominence due to their medicinal chem-
istry properties (Fig. 1).5
Sulfonimidates are a sulfur(VI) species bearing a tetrahedral
sulfur centre, with four different groups attached (this review
consistently represents them as S–O, S–C, SvN and SvO as
shown in Fig. 2). The stereogenic sulfur centre of sulfonimi-
dates can act as viable chiral templates that can be employed
in asymmetric syntheses – an important application that is dis-
cussed in detail in the latter part of this review. One of the
main advantages of such compounds is the possibility to
modify up to three points of diversity; the O–R1 bond, the S–C
(R2) bond and finally the nitrogen R3 substituent. The fore-
going R1 and R2 substituents bear carbon containing alkyl or
aryl moieties, whilst the broadest variation is found at the R3
substituent.6–16 Furthermore, sulfonimidates can be divided
into two categories, acyclic and cyclic sulfonimidates. Cyclic
variations of sulfonimidates arise when R1 and R3 are linked,
usually through a short carbon chain that has been derived
from chiral amino alcohols.
Aside from their most prominent application as building
blocks to access alternative sulfur(VI) compounds, sulfonimidates
have found uses as alkyl transfer reagents to acids, alcohols and
phenols,17 playing on the lability of sulfonimidates under acidic
conditions (also noted by Levchenko in 1967).1 In addition to
their acid sensitivity, they are also susceptible to elevated temp-
eratures, being converted into sulfonamides over extended
periods of time.18 The use of elevated temperatures can therefore
limit applications of sulfonimidates – but, in the case of
polymer synthesis, sulfonimidate decomposition at raised temp-
eratures proved a novel way to access poly(oxothiazene) poly-
mers8c and thionylphosphazene monomers and polymers.8d
Fig. 1 Drug candidates found with a sulfur(VI) centre.
Fig. 2 General overview of the sulfonimidate structure.
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The review is organised into two main sections – acyclic
and cyclic sulfonimidates. The topics reported have focused
on both seminal works as well as recent advancements on
important organic chemistry features including syntheses and
stereochemistry details where appropriate. Additionally, we
wish to highlight to the readership that a complete overview
focusing on a broad range of chiral sulfinyl compounds other
than sulfonimidates has just been published this year.2b
2. Synthesis of acyclic sulfonimidates
and their applications
2.1 Synthesis of acyclic sulfonimidates via sulfonimidoyl
halides
Most of the important early contributions towards the syn-
thesis of acyclic sulfonimidates were developed from the esteri-
fication of alcohols or phenols with racemic sulfonimidoyl
chlorides. Levchenko and co-workers discovered that oxidation
of arylsulfinyl chlorides 1 with sodium salts of
N-chloroarylsulfonamides afforded sulfonimidoyl chloride 2
(Scheme 1a).19 Alternatively, sulfonimidoyl chlorides 3 bearing
an N-alkyl moiety could also be accessed by the reaction of
N,N-dichloroalkylamines on arene sulfinyl chlorides 1.
Subsequent substitution of 3 with sodium phenoxides gave the
desired sulfonimidates 4 (Scheme 1b).1
In the 1970s, Johnson and co-workers identified an alternative
route to access sulfonimidoyl chlorides 6 through the oxidation of
sulfinamides 5 using either chlorine/N-chlorobenzotriazole,20a,b
or tert-butyl hypochlorite20c as the oxidant (Scheme 1c).
Reacting sulfonimidoyl chlorides 6 with either sodium alkox-
ides or sodium hydride-alcohol afforded sulfonimidates 7, fur-
thermore, O-alkyoxy reagents gave slightly higher yields than
the corresponding O-aryloxy derived reagents.20c This method-
ology was later utilized by Okuma and co-workers to access sul-
fonimidates (and subsequent transformation into amino
(aryloxy)-oxosulfonium salts by reaction with Et3OBF4).
21
Roy and co-workers disclosed that sulfonamides 8 react
with bulky halophosphoranes to undergo a rearrangement
reaction to access the key sulfonimidoyl chlorides 6
(Scheme 1d).8a The same group also disclosed that the bromo-
derivative of 6, sulfonimidoyl bromide, could be isolated when
Ph3PBr2 was used. The desired sulfonimidates 7 could be iso-
lated in yields of up to 78% after reacting sulfonimidoyl chlor-
ide 6 with alcohol and triethylamine at 0 °C for 2 hours.8a
Roy’s N-silylsulfonimidates synthesized via this method were
subsequently utilized in polymerization studies,8b,c investi-
gating the reactivity of the Si–N bond under thermal polycon-
densation conditions (Turner and co-workers also utilized
N-silylsulfonimidates to react with N-silylphosphoranimines,
giving access to thionylphosphazene monomers and
polymers).8d
In the 1970s, Johnson reported that access to optically
active sulfonimidates 12 could be achieved when starting the
synthesis from Andersen-type reagent (−)-menthyl (S)-benzene-
sulfinate 9 (Scheme 2). The starting reactant 9 has a known
absolute configuration, and previous studies from Johnson’s
group showed that reaction of 9 with nucleophiles such as the
lithium salt of methylamine or methyl magnesium bromide
proceed with inversion of configuration.22 Moreover, studies
by Montanari23 and Nudelman and Cram24 had previously
highlighted that displacement of sulfinates by lithium amine
salts occurs with inversion of configuration at sulfur, a similar
feature that was found in Johnson’s transformation of 9 to 10.
Subsequent oxidation of 10 to 11 (retention of configuration),
followed by reaction of sodium phenoxide with sulfonimidoyl
chloride 11 (inversion of configuration) afforded sulfonimidate
12. The transformation of 10 to 12 was carried out without iso-
lation of sulfonimidoyl chloride 11, which was found to race-
mise at high temperatures – maintaining 11 in an ethereal
solution at −78 °C and transferring it to a solution of phenox-
ide in DMF at 0 °C proved fruitful, affording sulfonimidate 12
in 69% optical purity (97% on recrystallisation). Furthermore,
Scheme 1 Important historical routes towards sulfonimidoyl chlorides
and sulfonimidates. (a) Levchenko’s synthesis of aryl-substituted sulfoni-
midoyl chlorides 2; (b) Levchenko’s route to N-alkyl derived sulfonimi-
doyl chlorides 3 and conversion to sulfonimidates 4; (c) Johnson’s oxi-
dative chlorination of sulfinamides 5 to access sulfonimidoyl chlorides 6,
and subsequent transformation into sulfonimidates 7; (d) Roy’s synthesis
of sulfonimidoyl halides 6 and sulfonimidates 7 from N-silylated sulfona-
mides 8 and dihalophosphoranes.
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during the oxidation step, pyridine was added as a hydrogen
chloride scavenger to avoid racemisation.25
The synthesis of sulfonimidates from sulfonimidoyl halides
has received a resurgence in attention – this may be due to the
fact that sulfonimidates are being identified as a useful inter-
mediate towards the synthesis of other sulfur(VI) containing
molecules found in drug discovery programmes, such as sul-
foximines and sulfonimidamides.
Nobel prize winner Barry Sharpless has recently expanded
his click-chemistry concept towards sulfur-fluoride exchange
chemistry or ‘SuFEx’ chemistry, and in 2018, reported the syn-
thesis of sulfonimidates 7 from sulfonimidoyl fluorides 13
(Scheme 3). The authors advocate the use of sulfonimidoyl flu-
orides over the analogous chlorides due to the latter’s lability
to hydrolysis. Sharpless showed that through DBU-promoted
formation of the S–O bond in the sulfonimidate product,
complex natural products containing a phenol motif including
(+)-δ-tocopherol and capsaicin could successfully be incorpor-
ated in excellent yields.26
Following on from Sharpless’s use of sulfonimidoyl fluor-
ides to access sulfonimidates, a joint research article from
Wright, Oehlrich and co-workers also in 2018 led to the devel-
opment of a bench stable sulfonimidate 15 that can be easily
scaled for medicinal chemistry programmes looking to access
CF3-derived sulfonimidamides 17/18 (Scheme 4).
27a The syn-
thesis of sulfonimidates was realised by reacting tetrafluoro-
phenol and sulfonimidoyl fluoride 14 – a precursor that the
same group previously reacted with amines directly to access
sulfonimidamides.27b The authors show that their sulfonimi-
date 15 had a few key advantages over its predecessor (sulfoni-
midoyl fluorides) for the synthesis of sulfonimidamides;
firstly, the sulfonimidate reagent was found to be more reactive
towards amines than sulfonimidoyl fluorides. Secondly,
during the sulfonimidamide formation reactions, the authors
report less unwanted sulfonamide by-product was observed
when the bench stable sulfonimidate was utilised. The authors
have shown a single example in which two equivalents of
methyl lithium were reacted with the sulfonimidate, affording
the desired sulfoximine 16 in 60% yield (Scheme 4).
Scheme 2 Johnson’s synthesis of optically active sulfonimidates 12.
Scheme 3 Sharpless’s synthesis of sulfonimidates from sulfonimidoyl
fluorides.
Scheme 4 Wright and Oehlrich’s bench stable sulfonimidate from sul-
fonimidoyl fluorides, and further applications of sulfonimidates.
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Building on the work of Sharpless’s SuFEx chemistry, this
year Zuilhof and co-workers reported the synthesis of sulfon-
imidates 20 from sulfonimidoyl fluorides 19 and phenols
(a silicon-free SuFEx approach).28 The authors show that utiliz-
ing a stoichiometric amount of base (DBU), the formation of the
target products can be achieved in excellent yields in short reac-
tion times (as little as 2 minutes, see Scheme 5). Moreover, sub-
mitting an enantioenriched sulfonimidoyl fluoride 21 afforded
sulfonimidates 22 in enantiomeric excesses up to 99% ee.
Three mechanistic routes were debated by the authors.
Their investigations on the asymmetric synthesis of sulfonimi-
dates ruled out an SN1 type intermediate, favoring a SN2 or
addition–elimination mechanism – enantiomeric excesses
were maintained when using an excess (10 equiv.) of good
nucleophilic phenols, and, ee was lost when a poor, electron-
deficient phenol was utilized. Furthermore, quantum chemical
calculations conducted show a preference for the addition–
elimination mechanism (potential energy surface analysis)
when sodium phenolate was used as a nucleophile – interest-
ingly, the calculations showed that DBU was not necessary to
aid fluoride loss when sodium phenolate was used as a nucleo-
phile source (Scheme 6).
In 2019, Ni and Hu reported the use of sulfonimidoyl fluor-
ides as reagents to affect the conversion of alcohols 23/26 into
alkyl fluorides 25/28 (Scheme 7).29 When 4-fluorophenethyl
derived alcohol 23 was reacted with SulfoxFluor in the pres-
ence of DBU, 19F NMR spectroscopy indicated that a sulfonimi-
date species 24 had formed after 3 minutes. After a further
10 minutes, slow consumption of sulfonimidate 24 provided
the desired alkyl fluoride product 25. The absence of DBU
resulted in no reaction. In their proposed mechanism, DBU
deprotonates the alcohol species 26 giving the alcoholate
anion, that undergoes nucleophilic addition to SulfoxFluor to
furnish a pentacoordinate intermediate. Protonated DBU pro-
motes the loss of fluorine to yield sulfonimidate 27, that sub-
sequently undergoes nucleophilic displacement by DBU-HF to
produce the alkyl fluoride 28, along with a sulfonamide salt.
2.2 Synthesis of acyclic sulfonimidates from sulfinyl
hydroxylamines and applications as alkyl transfer reagents
In 1973, Maricich et al. showed that sulfinyl hydroxylamines
29 undergo a rapid rearrangement to sulfonimidates 32/33, in
which an alkoxy group migrates from the nitrogen to the
Scheme 5 (a) Zuilhof’s synthesis of sulfonimidates using a silicon free
approach; (b) synthesis of optically active sulfonimidates.
Scheme 6 Zuilhof’s proposed mechanistic routes to access sulfonimi-
dates 20 and 22.
Scheme 7 Ni and Hu’s deoxyfluorination of alcohols.
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sulfur atom.30 The sulfonimidates formed were unstable and
were found to transfer their alkyl group to a range of alcohols
when heated at 50 °C forming ethers 35 along with the corres-
ponding sulfonamide 34 (Scheme 8).
The reaction proceeds via a mechanism involving sulfoni-
midate species 32 or 33, that may have been formed through a
dissociation process of the migrating alkoxy group and the
solvent (ROH). Two possible sulfonimidates were postulated
that could transfer the alkyl substituent to the alcohol. They
also believe that a delocalised nitrenium species 30/31, stabil-
ised by the sulfinyl electron pair is possible, and this was sup-
ported when cyclic N-acyl derivative 36 failed to rearrange after
refluxing in ortho-dichlorobenzene for 20 hours, since the
nitrenium ion from 36 would be destabilised by the N-acyl
group (Scheme 9).
In 2013, the same author exploited the application of their
sulfonimidate rearrangements, utilizing them as alkyl transfer
reagents to a range of acids, alcohols and phenols.17 Utilizing
nitro-containing sulfonimidate 38, the ethylation of acids to
esters was achieved without a catalyst – however, the reaction
required catalytic amounts of fluoroboric acid-dimethyl ether
complex (10 mol%) for the conversion of alcohols and phenols
to ethers (yields up to 94%, Scheme 10). For each reaction con-
ducted, the side product isolated was the resulting sulfona-
mide 39 from the sulfonimidate reagent.
2.3 Synthesis of acyclic sulfonimidates from sulfinamides
utilising hypervalent iodine species & applications towards
sulfoximine synthesis
Malacria and co-workers reported that sulfonimidates 41 could
be formed from sulfinamides 40, iodosobenzene and alcohols
in a one-pot procedure, utilising mild conditions, allowing
access to a broad range of sulfonimidates in yields up to 95%
(Scheme 11).6 The reaction tolerated a variety of primary alco-
hols (except benzyl alcohol), and further limitations were
found on increasing the steric hindrance on the alcohol – iso-
propyl alcohol required a longer reaction time, whilst reaction
failure was observed when using tert-butanol. Furthermore,
phenol only resulted in degradation, with no O-aryl sulfonimi-
date formed.
Malacria’s procedure built upon the initial report of
Maricich’s N-alkoxybenzenesulfinamides,30 in which they devised
a way of oxidising the sulfinamide to form the key N–O bond,
Scheme 11 Malacria’s synthesis of sulfonimidates from sulfinamides
and iodosobenzene.
Scheme 8 Maricich’s proposed mechanism of alkyl transfer to
alcohols.
Scheme 9 Maricich’s attempted rearrangement of N-acyl derived
N-alkoxybenzenesulfinamides 36.
Scheme 10 Maricich’s sulfonimidate 38, and its application as an alkyl-
ation transfer reagent.
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and minimised the amounts of unwanted sulfonamide 42 that
was known to occur when oxidants such as m-CPBA were
employed.31 The use of a mild oxidising agent derived from
iodine(III)32 allowed the necessary N–O bond formation to
proceed smoothly (Scheme 11).
Their initial mechanistic proposal is highlighted in
Scheme 12 – solvation of iodosylbenzene 43 in the desired
alcohol, followed by attack on 44 by sulfinamide species 45
initiates the synthesis.6,33 This species can form a dissociated
intermediate 47, that in the presence of the remaining alkoxide
anion 48 can re-attack the nitrogen centre and expel the iodoben-
zene moiety to give the key N-alkoxybenzenesulfinamides inter-
mediate 49, first identified by Maricich (Scheme 8). This can
then rapidly rearrange to yield the key sulfonimidate product 33.
During the course of conducting an asymmetric version of
the above transformation, the authors found that the reaction
proceeded with retention of configuration at the sulfur centre
in the product. As a result of these findings, Malacria proposed
an alternative, more reasonable model (Scheme 13) – initial
sulfinamide 51 attack on solvated iodosylbenzene 50 yields
intermediate 52. A rearrangement of 53 via a 6-electron tran-
sition state allowed access to sulfonimidates 54 with retention
of configuration (Scheme 13a). However, from intermediate 53,
an alternative route via an three-atom rearrangement (first
reported by Reggelin and co-workers)34 would afford a sulfoni-
midoyl iodonium 55 – a species that could be responsible for
loss in enantiomeric excess during the transformation, yield-
ing sulfonimidate 56 (Scheme 13b).
In 2006, Malacria showed that N-aryl sulfinamides 57 could
also be utilised in the formation of sulfonimidates 58 with
their one-pot procedure utilising diacetoxyiodobenzene. With
these examples, aryl derived sulfinamides required diacetox-
yiodobenzene (DIB) and a mild base such as magnesium oxide
to achieve high yields (Scheme 14).7
In 2018, Bull, Luisi and co-workers have most recently
reported the conversion of aryl thiols 59 into sulfonimidates
60 utilising hypervalent iodine reagents and ammonium car-
bamate as nitrogen source (Scheme 15).16 Using a 4-equivalent
loading of ammonium carbamate forced the reaction to
produce exclusively sulfonimidate (at 1 equivalent of nitrogen
source, sulfonamide was formed as the major reaction
product). The reaction scope allowed a range of aryl thiols to
participate in the reaction – substitution on the aromatic ring
at ortho, meta and para with both electron withdrawing and
donating substituents were well tolerated affording sulfonimi-
dates in good yields. In one case, a cycloalkylthiol was sub-
mitted to the optimised conditions, and the desired sulfonimi-
date was isolated in moderate yield. Whilst the exact sequence
of events to form the sulfonimidate 60/64 from thiol 59 is
unclear, the mechanism of Bull and Luisi’s method was based
on a range of control experiments that allowed the identifi-
cation of disulfides 61 and sulfinate esters 62 during the reac-
tion (Scheme 15).
In the same year, Stockman and co-workers utilized sulfoni-
midates 7 as versatile intermediates to access a broad library
of sulfoximines 66.35 Building on the methodology developed
by Malacria and co-workers, Stockman utilized iodosylbenzene
to oxidise a range of sulfinamides 65 in an excess of alcohol as
solvent to access a range of sulfonimidates that differ at three
key positions (Scheme 16). During the oxidation reaction, mod-
Scheme 12 Malacria’s initial mechanistic proposal for the formation of
sulfonimidates 33.
Scheme 13 Malacria’s revised mechanism for the preparation of
sulfonimidates.
Scheme 14 Malacria’s synthesis of arylsulfonimidates.
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ifying the R1 substituent to include allyl, cyclopropyl, methyl
and phenyl moieties were all well tolerated – inclusion of a
tert-butyl group however proved unsuccessful. Furthermore, a
range of primary alcohols could be incorporated, as well as
varying the N-moiety of the sulfinamide 65 (cycloalkyl, tert-
butyl, substituted aryls) without loss of reactivity in the trans-
formation. A broad library of sulfonimidates 7 (where OR3 was
OEt) were then converted to sulfoximines 66 by Grignard dis-
placement of the OR3 group.
In 2019, Bolm and co-workers used O-benzotriazolyl sulfo-
nimidates 69/70 as active intermediates in order to access sul-
fonimidamides 71 (Scheme 17).36 Their group reported that
aromatic or heteroaromatic diazonium salts 68 could be reacted
with N-tritylsulfinylamine 67 37 and 1-hydroxybenzotriazole
hydrate with 1.1 equiv. of N-methyl-piperidine gives the desired
sulfonimidates 69. The method utilizes dimethyl carbonate, a
green solvent for synthesis, and benefits from fast reaction
times. As shown in Scheme 17, a range of functional groups
from the diazo-aryl/heteroaryl moiety were well tolerated under
the reaction conditions, providing structural diversity. Control
experiments with TEMPO as radical scavenger showed complete
suppression of sulfonimidate formation, indicating a potential
radical mechanism involving pre-organized aggregates of the
reactants. Bolm also showed that sulfonimidates 70 could be
converted into sulfonimidamides 71 through reaction with
either primary or secondary amines (2.0 or 1.2 equiv., respect-
ively) under basic conditions (Scheme 17b). To highlight just a
few of the examples, aliphatic amines such as ethylamine, thio-
morpholine and azepane reacted smoothly affording the target
sulfonimidamides 71 in good yields.
3. Synthesis of cyclic sulfonimidates
3.1 Synthesis of cyclic sulfonimidates via sulfonimidoyl chlorides
The research reported by the group of Reggelin has dominated
this particular field of sulfur(VI) chemistry over the last three
decades. In Reggelin’s seminal work on the synthesis of cyclic
sulfonimidates in 1992, a one pot procedure in which (S)-O-tri-
methylsilyl valinol 72 and p-toluenesulfinyl chloride 73 were
reacted accessing sulfinamide 74, followed by an oxidation
affording the desired sulfonimidate products 75a and 75b
without need of isolating reaction intermediates
(Scheme 18).38 Reggelin utilised potassium fluoride to conduct
the desilylation of the primary alcohol, thus allowing the cycli-
sation to occur. Furthermore, sulfonimidates 75a and 75b were
reacted with various organometallic reagents affording sulfoxi-
mines in up to quantitative yields.
In 1995, Reggelin followed up his seminal work by report-
ing an alternative route to access cyclic sulfonimidates 78
Scheme 15 Bull and Luisi’s sulfonimidate 60/64 synthesis from aryl
thiols 59.
Scheme 16 (a) Stockman’s synthesis of sulfonimidates 7 and, (b) appli-
cation of sulfonimidates to access a diverse library of sulfoximines 66.
Organic & Biomolecular Chemistry Review

































































































(Scheme 19).39 Sulfinamides 76 bearing chiral amino alcohols
were identified as suitable starting materials that would be
subjected to oxidative chlorination conditions to afford sulfo-
nimidoyl chlorides 77. Previous reports by Johnson and Cram
independently showed that sulfinamides are oxidised using
tert-butyl hypochlorite at low temperatures to give sulfonimi-
doyl chlorides, proceeding with retention of configuration.25,40
However, sulfonimidoyl chlorides are not configurational
stable at raised temperatures used in ensuing nucleophilic
reactions.25 Reggelin showed that intramolecular attack of the
internal alcohol at the sulfur centre, in the presence of DBU,
was expeditious at −78 °C, and that the desired isomeric purity
of the starting material is retained in the isolated product.
Nearly two decades ago, Reggelin shed light on the mecha-
nism believed to be in operation during the synthesis of cyclic
sulfonimidates.34 He found through optimisation reactions
that two particular pathways were in operation, depending on
the base used in the reaction (Scheme 20). Oxidative cyclisa-
tion of an enantiomer of sulfinamide involved two key stereo-
selective steps; the first process is an oxidative chlorination
reaction to afford sulfonimidoyl chloride intermediate 81,
that proceeds with retention of configuration at sulfur. The
mechanism of this chlorination was proposed to firstly involve
chlorination of the nitrogen, followed by rearrangement to give
the sulfonimidoyl chloride, which was supported through
NMR control experiments (integration of meta-aromatic
signals to NH signal changed from 2 : 1 to 3.58 : 1 during the
course of the chlorination reaction). The second step is a base-
induced cyclisation. If the base used is bulky, for example,
DBU, and the reaction conducted at low temperatures,
the chloride is displaced directly by the tethered alcohol in
a SN2-like fashion, giving the product with inversion of con-
figuration at sulfur (path a, Scheme 20). However, when di-
methylethylamine was used as a smaller, more nucleophilic
base (path b), sulfonimide ammonium salt 82 would be gener-
ated as an intermediate, which in turn could undergo base-
catalysed cyclisation to form sulfonimidate 75b with retention
of configuration due to a double displacement. A third
pathway was identified (path c), which shows that if the base
used is not strong enough, such as pyridine or 2,6-lutidine, then
hydrolysis of the intermediate sulfonimidoyl chloride was found.
This intricate procedure comes with a few drawbacks;
firstly, the separation of diastereomeric sulfinamide starting
materials is necessary (crystallisation and recrystallisation is
required to purify the cyclic sulfonimidate products). During
Scheme 17 (a) Bolm’s synthesis of sulfonimidates 69 from
N-tritylsulfinylamine 67, heteroaromatic diazonium salts 68 and
1-hydroxybenzotriazole; (b) application to access sulfonimidamides 71
from sulfonimidates 70.
Scheme 18 Reggelin’s one-pot synthesis of cyclic sulfonimidates 75.
Scheme 19 Reggelin’s synthesis of cyclic sulfonimidates 78.
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these recrystallizations, the authors disclose that for each sul-
fonimidate shown in Scheme 20, a maximum yield of around
35% was achieved for each epimer.
In the same article, Reggelin later described the conversion
of the sulfonimidoyl chlorides 81 into sulfonimidoyl bromides
84 using 1.2 equivalents of KBr and 5 mol% 18-crown-6
(Scheme 21). These species were initially thought to be labile,
albeit undetectable intermediates, yet NMR studies conducted
at −20 °C showed <5% of a species that was not the chloride
81, but potentially the bromide 84. Through further NMR
experiments at low temperatures, they observed that starting
from either a 1 : 1, 18 : 1 or 1 : 5 diastereomeric mixture of sulfi-
namides 79/epi-79, an enriched ratio of 9 : 1 was observed in
favour of the final sulfonimidate product 75b. The catalyst
loading was found to be crucial in maintaining the stereo-
selectivity and found that at catalyst loadings of 0.5 mol%, the
selectivity halved to 4.6 : 1 in favour of the target sulfonimidate
75b. The reaction was impressively shown to be reproducible
on a large scale (checked up to a 300 g scale). The authors
reported that the bromides react faster than chlorides.
Furthermore, fast interconversion between the epimers is
observed (dynamic epimer differentiation, in which epi-84
reacts 9–10 times faster than 84).
3.2 Cyclic sulfonimidates as chiral templates to access
sulfoximines
In 1994, Reggelin and co-workers utilized their chiral sulfoni-
midate template 75a to access enantiomerically pure allyl-
derived sulfoximines.41 After reaction of the sulfonimidate
core with allyl lithium,38 the desired sulfoximines 85 were
accessed (Scheme 22). Subsequently, the authors utilized a
deprotonation and transmetallation step to obtain optically
active titanated 2-alkenylsulfoximines 86 – such compounds
could be reacted with aldehydes (2-methylpropanal shown
below) under γ-hydroxyalkylation conditions to access chiral
allyl alcohol substrates (product 87 was obtained in 86% yield
starting from 85).
The synthesis of important oxygen and nitrogen containing
heterocyclic compounds42 was realized using the common
intermediate derived from alkenyl organometallic addition to
optically active cyclic sulfonimidate 75. The diastereoselective
γ-hydroxyalkylation of 2-alkenylsulfoximines 88 with enantio-
meric lactaldehydes afforded tri- and tetrasubstituted tetra-
hydrofuran derivatives 89a/b (shown in Scheme 23).42a They
were also able to access pyrrolidine derivatives 90 from the
addition of α-aminoaldehydes to titanated 2-alkenylsulfoxi-
mines as the key synthetic step.42b Moreover, the oxabicyclic
Scheme 20 Oxidative chlorination of sulfinamides and cyclisation of
the generated sulfonimidoyl chlorides to the target sulfonimidates 75a
and 75b.
Scheme 21 Formation of sulfonimidoyl bromides 84 and their epimeri-
sation and interconversion.
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systems could be accessed from (2-cyclohexenylmethyl)
sulfoximines.42c
Following on from their studies on using metalated 2-alke-
nylsulfoximines to access (poly)heterocyclic ring systems,
Reggelin showed that reacting α- and β-aminoaldehydes
with a range of titanated 2-alkenylsulfoximines allowed
access to highly substituted aza(poly)cyclic compounds 94
(Scheme 24).42d Moreover, the authors employed 2-alkenylsul-
foximines 91 bearing a range of chiral units (derived from cyclic
sulfonimidates 75a/75b, allowing variation of the configuration
at the sulfur atom and also at the amino alcohol carbon chiral
centre) to control the stereochemical outcome in the final het-
erocycles obtained. Depending on the ring size of the hetero-
cycle required, a range of preformed α- and β-aminoaldehydes
could be reacted with titanated 2-alkenylsulfoximines, followed
Scheme 22 Reggelin’s synthesis of alkenyl sulfoximines 85 and further
modifications to 86 and 87.
Scheme 23 Application of 2-alkenylsulfoximines 88 towards the con-
struction of important organic heterocycles 89 and 90. Reaction con-
ditions: (a) nBuLi, THF, −78 °C; (b) ClTi(OiPr)3, 0 °C; (c) aldehyde, −78 °C;
(d) (NH4)2CO3; (e) Bu4NF; (f ) n-BuLi, toluene, −78 °C; (g) ClTi(OiPr)3,
0 °C; (h) FMOC-protected α-aminoaldehydes, −78 °C; (i) piperidine,
20 °C, (NH4)2CO3, NH4Cl; ( j) K2CO3, MeOH; BOC2O, NaHCO3; (k) SmI2.
Scheme 24 General overview of route to accessing (poly)heterocyclic
ring systems 94, and some of the key compounds explored in biological
assays.
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by nitrogen driven nucleophilic attack intramolecularly on the
acceptor-substituted olefin bond in the vinyl sulfoximines to
generate the desired heterocyclic core structures. Access to this
key intramolecular nucleophilic attack is a result of piperidine
driven cleavage of the nitrogen Fmoc group (the authors also
use hydrazine when the nitrogen atom is protected with phtha-
lic anhydride, a method that benefits from an easily separable
phthalhydrazide byproduct). A final samarium iodide/lithium
naphthalenide/RANEY®-nickel cleavage of the sulfonimidoyl
moiety affords the nitrogen heterocycles.
During the allyl transfer step, chirality at the carbon atoms in
the newly formed bond was controlled by both the prochirality
of the double bond, and sense of chirality in the sulfur auxiliary.
Examples of nitrogen heterocycles accessed using this approach
include pyrrolidines, piperidines, pyrrolizidine, benzopiperi-
dines, 2-azabicycloalkanes and azapolycycles. A number of the
molecules synthesized using this protocol were aiming to be
type III peptidomimetics – an important group of pharmaceuti-
cals targeting enzyme inhibition. Two heterocyclic ring systems
were tested for bioactivity in NK1-functional assays; both pyrroli-
dine derivative 95 and azabicycle 96 showed high activities.
This work was further extended by exploring the synthesis
of endocyclic 2-alkenyl sulfoximines (derived from sulfonimi-
date template 75b) bearing an additional heteroatom (nitro-
gen) or group (acetal, that could later be converted into the
ketone), thereby installing an extra point of diversity into ring
system 1 (see Scheme 24 for numbering of rings) on the
bicycles generated. Some examples of the endocyclic 2-alkenyl
sulfoximines 97–100 employed by Reggelin in this subsequent
work are shown below in Fig. 3.42e
One issue that was further addressed utilizing this type of
methodology was the cleavage of the sulfonimidoyl auxiliary in
tandem with C–C bond formation to give the desired azaheter-
ocyclic systems.42f Whilst RANEY® Nickel, lithium naphthale-
nide and samarium iodide all facilitate the transformation,
they result in a methyl group in the desired product which is
unable to undergo further modifcations (see Scheme 24, 93→ 94).
Utilizing a technique employed by Julia and co-workers for
the olefinating desulfurization of sulfones using haloalkylmag-
nesium/lithium derived carbenoids,43 Reggelin was able to
remove the sulfonimidoyl moiety in compound 101 employing
the carbenoid iodomethylmagnesium iodide. The resulting
olefin products 102 from β-elimination could be isolated in good
to excellent yields (selected examples shown below, Scheme 25).
These metalated sulfoximines proved integral towards the syn-
thesis of important natural products, for example, euglobals G1
and G2 and arenaran A.42g 2-Oxabicyclo[n.3.0]alkane core struc-
tures were accessed using 2-cyclohexenylmethyl- and 2-cyclopen-
tenylmethyl sulfoximines in an overall one-pot approach.
Cyclic sulfonimidates also proved to be important building
blocks to access bis(sulfoximines).44 Subjecting one equi-
valent of the cyclic template 75b to MeLi gave the mono-
sulfoximine product, but deprotonation with LHMDS and
reaction with a further equivalent of template 75b gave the
desired bis(sulfoximine) product 103 in 62% yield (one-pot)
(Scheme 26). The designed bis(sulfoximines) were trialled as
ligands in copper catalysed 1,4-additions to 2-cyclohexenone.
Enantiomeric excesses for the isolated addition products
reached up to 36% ee.
In 2012, Reggelin discussed methods to cleave the template
from bis-sulfoximines (two main examples highlighted),
affording free NH-bis sulfoximines. Firstly, a racemic para-
methoxyphenyl derived template 104 was subjected to DDQ
oxidation conditions – the desired racemic bis-NH sulfoximine
105 was obtained in up to 54% yield (Scheme 27a). For their
aforementioned optically active valinol derived template 103,
these conditions could not be employed. Instead a three-
step protocol, including a mesylation, bromination and a final
Fig. 3 Endocyclic 2-alkenyl sulfoximines 97–100 employed to add a
further point of diversity to bicyclic ring systems.
Scheme 25 Reggelin’s C–C bond-forming desulfurizations of
sulfoximines.
Scheme 26 Utilization of template 75b to access bis(sulfoximines) 103.
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zinc induced β-elimination, afforded the enantiomerically pure
NH-bis-sulfoximine 106 (see Scheme 27b).45
The same group later applied these cyclic sulfonimidates
to access optically active phosphanylated sulfoximines 107 –
these compounds were subsequently employed as ligands
in palladium-catalyzed allylic substitution reactions
(Scheme 28).46 The ligands can be accessed through a short
synthetic route over 4 steps, and ligand 107 was found to be
highly enantioselective when applied in the palladium-cata-
lyzed asymmetric allylic substitution of 1,3-diphenylallyl
acetate and dimethylmalonate.
Sulfonimidates such as 75b were also shown to participate
as electrophiles in Barbier-type reactions with dihalomethanes
and n-BuLi (Scheme 29). Reggelin showed that S-(chloro-
Scheme 27 (a) DDQ promoted cleavage of the PMP group towards
racemic bis-NH sulfoximines 105; (b) three-step procedure to access
optically active bis-NH sulfoximines 106.
Scheme 28 (a) Synthesis of ligand 107 from sulfonimidate 75a; (b) util-
ization of ligand 107 in allylic substitution reactions.
Scheme 30 (a) Stockman’s general route to enantioenriched NH-sul-
foximines 113; (b) Grignard additions to sulfonimidate derived template
114; (c) oxidative debenzylation of sulfoximines 115 to give NH-sulfoxi-
mines 116.
Scheme 29 Reggelin’s route to access oxathiazines 109 from cyclic
sulfonimidates 75b.
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methyl)sulfoximines 108 from this reaction could then be
reacted with potassium hydride in THF to access their desired
oxathiazines 109.47 The protocol could also be conducted in a
one-pot synthesis, providing a good yield of 66% for the
desired oxathiazines 109.
In 2020, the Stockman group reported that optically active
cyclic sulfonimidate templates 111 could be employed to
access enantioenriched NH-sulfoximines 113 (overall route
shown in Scheme 30a).48 Building on the work reported by
Reggelin and co-workers, amino acid derived phenyl glycinol
provided a suitable auxiliary that could be carried through the
oxidation of sulfinamides 110 using t-BuOCl/DBU to give cyclic
sulfonimidates 111, followed by a Grignard addition step to yield
sulfoximine products 112. Importantly, the auxiliary could be
easily removed using molecular oxygen under basic conditions
in MTBE to obtain the final NH-sulfoximines 113 whilst main-
taining optical purity. For clarity, one epimer is shown in
Scheme 30, however, the reaction proceeds smoothly for the
other epimer as well under the reaction sequence, resulting in
isolation of the opposite enantiomers of 113 shown (in simi-
larly high enantiomeric excesses). Such optically active com-
pounds synthesized mimic structures of chiral sulfoximines
currently involved in drug discovery programmes, and as such
may provide a useful tool to accessing necessary enantiomers
for future drug molecule syntheses.
4. Conclusions
This review article has summarised the synthetic approaches
to access sulfonimidates, and their various utilities and appli-
cations towards accessing high value compounds over the last
half century. Since their discovery, a plethora of methods have
been discovered to access these molecules. With the presence
of a stereogenic tetrahedral sulfur centre, sulfonimidates have
found applications as chiral templates to access enantio-
enriched sulfoximines – these in turn can subsequently be
converted into other chiral molecules including highly substi-
tuted saturated heterocycles. In other cases, exploiting weak-
nesses of sulfonimidates, including acid sensitivity and heat
lability, have led to important discoveries, such as acting as
alkyl transfer agents or the synthesis of sulfur containing poly-
mers. Due to the rising interest in other sulfur(VI) compounds
including sulfonimidamides and sulfoximines as pharma-
ceutical leads in the medicinal chemistry sector, the need to
develop fast, efficient routes using sulfonimidates as reactive
(and potential optically active) intermediates is ever present.
To address the growing need for routes to access these sought-
after molecules, we envisage this field to continue to expand
over the coming years. Sulfonimidate chemistry still offers
many undiscovered leads and applications, which we antici-
pate to see in the near future.
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